NEW YORK, July 29, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Digital Pathology Systems Industry
http://www.reportlinker.com/p01171461/Global-Digital-Pathology-Systems-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
This report analyzes the worldwide markets for Digital Pathology Systems in US$ Million.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.
The report profiles 46 companies including many key and niche players such as 3DHISTECH Ltd., AccelPath, Inc., Apollo PACS, Inc., Carl Zeiss MicroImaging GmbH, Corista LLC, Definiens AG, DigiPath Inc., Flagship Biosciences, LLC, Koninklijke Philips Electronics N.V., Leica Microsystems GmbH, Aperio Technologies, Inc., MikroScan Technologies, Inc., Olympus America, Inc., Omnyx, LLC, Pixcelldata Ltd., Ventana Medical Systems, Inc., BioImagene, Inc., and VMscope GmbH. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3II. ECUTIVE SUMMARY
1. OUTLOOK II-1
A Prelude II-1
Current & Future Analysis II-1
Key Trends and Drivers II-2
Challenges Ahead for Digital Pathology Systems II-2
2. INDUSTRY OVERVIEW II-3Traditional Pathology Workflow - A Cumbersome Process Lacedwith Issues II-3The Evolution of Digital Pathology Systems II-3Digital Pathology Products and Procedures II-4Digital Pathology as a Service Eludes Cost-based Issues II-4Applications of Digital Pathology and the Need for aManagement System II-5Digital Pathology in Treatment of Cancer and Other Diseases II-5Digital Pathology in the Clinical Research Scenario II-5Telepathology Expected to Pave Way for Pathology Outsourcingto Developing Nations II-6Cloud Hosting and Web-based Applications Offer Cost-EffectiveDigital Pathology Options II-6A Review of Information Archival and Retrieval in DigitalPathology II-6Storage and Interoperability II-7Location and Internal Communication II-7Systems and Data Reliability II-7Image Life-Cycle Management II-8IT infrastructure and Management Costs II-8Factors Affecting Information Archival II-8
3. COMPETITION II-9
Leading Players II-9
Table 1: Leading Players in the Global Digital Pathology
Systems Market (2012): Percentage Breakdown of Dollar Sales
for Leica/Aperio, Ventana, Olympus and Others (includes
corresponding Graph/Chart) II-9
Consolidation Rife in the Digital Pathology Space II-9
Leica's Acquisition of Aperio - The Underlying Rationale II-10
4. PRODUCT OVERVIEW II-11An Introduction to Pathology II-11What is Digital Pathology? II-11Benefits of Digital Pathology II-11Access to Digital Slide Images Anytime Anywhere II-12Digital Pathology Management Systems II-12Easier Analysis and Retrieval of Digital Images II-12Applications II-13Remote Reviewing II-13Digital-Assisted Mathematical Analysis II-13Data Storage II-13Telepathology II-13Static Telepathology II-14Dynamic Telepathology II-14Hybrid Telepathology II-14Bio-banking II-14Multinational Integration II-14Tissue Microarray Analysis II-15
5. PRODUCT INTRODUCTIONS/INNOVATIONS II-16
Ventana Medical Systems Launches iScan HT Slide Scanner II-16
Aperio Technologies Introduces Release 11.0 of Digital
Pathology System II-16
Omnyx Showcases Upcoming Integrated Digital Pathology Solution II-16
Pixcelldata Unveils Collibio Desktop Version II-17
Carl Zeiss MicroImaging Launches LSM 700 Microscope II-17
Agfa Healthcare Unveils Integrated Digital Pathology Solution II-17
Leica Microsystems Expands Capabilities of Leica SCN400 and
SCN400 F Scanners II-18
Omnyx Unveils Omnyx™ VL4 Scanner to Beta Consumers II-18
Leica Microsystems Launches Total Digital Pathology Solution II-19
Definiens® Unveils Quantitative Digital Pathology Portfolio II-19
Aperio Technologies Introduces ScanScope AT Pathology Slide
Scanner II-20
MikroScan Technologies Unveils MikroScan D2 Slide Imaging Scanner II-20
Caliper® Life Sciences Introduces Vectra™ 2 with AQUA
Technology for Quantification of Protein Biomarkers II-21
Philips to Introduce Digital Pathology Technology II-21
BioImagene Launches Digital Pathology Solutions in Europe II-21
BioImagene Unveils Next Generation Virtuoso™ and iScan Coreo
Au Slide Scanner II-21
Definiens Develops Novel Software Application II-22
MikroScan Technologies Unveils New Product Range II-22
Aperio Technologies Unveils Discover Your Path Assessment
Program for Hospitals II-23
CBLPath Introduces Best Practice™ Partnership Program II-23
Nikon Instruments Launches Mi Macro Imaging Grossing Station II-23
Definiens Introduces Definiens Tissue Studio II-24
BioImagene Introduces Crescendo DPW II-24
Aperio Technologies Introduces Clinical Partner Service Program II-24
Targeted Molecular Diagnostics Introduces Digital Pathology
Services in China II-25
Applied Spectral Imaging Launches PathEx Duo Detection System II-25
Aperio Technologies Launches Digital IHC Solution II-25
Visuvi and BioImagene Launch PathSearch™ II-26
Amirsys Integrates PathIQ ImmunoQuery with Virtuoso of BioImagene II-26
6. RECENT INDUSTRY ACTIVITY II-27Leica Biosystems Takes Over Aperio Technologies II-27Carl Zeiss MicroImaging and Olympus America Sign LicensingAgreement II-27Aperio Technologies and Dell Enter into Strategic Collaboration II-28Erasmus MC Selects Philips to Adopt Digital Pathology System II-28Leica Microsystems and Indica Labs Sign Agreement II-28Ventana Medical Systems Obtains USFDA 510(k) Clearance forVENTANA Companion Algorithm Ki-67 (30-9) Image AnalysisSolution II-28AccelPath Acquires DigiPath Solutions II-29Omnyx™ Receives CE Mark in Europe II-29XStor Systems and Quorum Technologies Enter Into DistributionPartnership II-29Royal Philips Electronics and NEC Ink Agreement II-30GE Healthcare Enters into Partnership with Singapore GeneralHospital II-30PathXL Enters into Partnership with Visiopharm II-31Aperio Technologies Enters into Partnership with Definiens toMarket Definiens Tissue Studio™ II-31Caliper Life Sciences Takes Over CRi II-32Ventana Medical Systems Takes Over BioImagene II-32Leica Microsystems Acquires Genetix II-32Dartmouth-Hitchcock Medical Center to Deploy BioImagene Solutions II-33Royal Philips Electronics Ink Cooperation Agreement withDefiniens II-33UPMC and GE Healthcare Enter into Joint Venture II-33i-Path Diagnostics and iSOFT Group to Enter into Partnership II-34KUMC and BioImagene Enter into Collaboration II-34CRi and 3DHISTECH Ink Exclusive Agreements II-34BioImagene and LigoLab Develop New Interface II-35Olympus America and Omnyx Ink Nonexclusive Global LicensingAgreement II-35Aperio Technologies and ADCIS Enter into Partnership II-35VMscope and Pixcelldata Enter into Partnership II-36Aperio Technologies Receives Patent from United States Patentand Trademark Office II-36Royal Philips Electronics and Dako Ink Agreement II-36Dako Signs Agreement with Omnyx II-37Flagship Biosciences Inks Service Partnership with ExpressionPathology II-37Flagship Biosciences Establishes Digital Pathology office inBoston Suburbs II-38Omnyx to Commence Clinical Research Testing of OmnyxIntegrated Digital Pathology Solution II-38Henry Ford Health System to Deploy PathPACS® of Apollo PACS II-38Genetix Takes Over SlidePath II-39Omnyx Receives Patent from US Patent and Trademark Office II-39
7. FOCUS ON SELECT GLOBAL PLAYERS II-40
3DHISTECH Ltd. (Hungary) II-40
AccelPath, Inc. (US) II-40
Apollo PACS, Inc. (US) II-41
Carl Zeiss MicroImaging GmbH (Germany) II-41
Corista LLC (US) II-42
Definiens AG (Germany) II-42
DigiPath Inc. (US) II-42
Flagship Biosciences, LLC (US) II-43
Koninklijke Philips Electronics N.V. (Netherlands) II-43
Leica Microsystems GmbH (Germany) II-44
Aperio Technologies, Inc. (US) II-44
MikroScan Technologies, Inc. (US) II-45
Olympus America, Inc. (US) II-45
Omnyx, LLC (US) II-46
Pixcelldata Ltd. (Ireland) II-46
Ventana Medical Systems, Inc. (US) II-46
BioImagene, Inc. (US) II-47
VMscope GmbH (Germany) II-47
8. GLOBAL MARKET PERSPECTIVE II-48Table 2: World Recent Past, Current and Future Analysis forDigital Pathology Systems by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), and Rest ofWorld Markets Independently Analyzed with Annual Revenues inUS$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-48
Table 3: World Historic Review for Digital Pathology Systems
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Revenues in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) II-49
Table 4: World 15-Year Perspective for Digital PathologySystems by Geographic Region - Percentage Breakdown ofRevenues for US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), and Rest of World Markets for Years 2004,2012, and 2018 (includes corresponding Graph/Chart) II-50III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Current & Future Analysis III-1
Regulatory Scenario in the US III-1
Health Insurance Portability and Accountability Act (HIPAA) III-1
Food and Drug Administration (FDA) III-1
Clinical Laboratory Improvement Amendments (CLIA) III-1
Product Launches III-2
Strategic Corporate Developments III-8
Key Players III-16
B.Market Analytics III-22
Table 5: US Recent Past, Current and Future Analysis for
Digital Pathology Systems with Annual Revenues in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-22
Table 6: US Historic Review for Digital Pathology Systemswith Annual Revenues in US$ Million for Years 2004 through2009 (includes corresponding Graph/Chart) III-23
2. CANADA III-24
A.Market Analysis III-24
Current & Future Analysis III-24
Need for Digital Pathology in Canada III-24
Strategic Corporate Development III-24
B.Market Analytics III-25
Table 7: Canadian Recent Past, Current and Future Analysis
for Digital Pathology Systems with Annual Revenues in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-25
Table 8: Canadian Historic Review for Digital PathologySystems with Annual Revenues in US$ Million for Years 2004through 2009 (includes corresponding Graph/Chart) III-26
3. JAPAN III-27
Market Analysis III-27
Table 9: Japanese Recent Past, Current and Future Analysis
for Digital Pathology Systems with Annual Revenues in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-27
Table 10: Japanese Historic Review for Digital PathologySystems with Annual Revenues in US$ Million for Years 2004through 2009 (includes corresponding Graph/Chart) III-28
4. EUROPE III-29
A.Market Analysis III-29
Current & Future Analysis III-29
Product Launches III-29
Strategic Corporate Developments III-33
Key Players III-37
B.Market Analytics III-41
Table 11: European Recent Past, Current and Future Analysis
for Digital Pathology Systems by Country/Region - France,
Germany, Italy, UK, Spain, and Rest of Europe Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-41
Table 12: European Historic Review for Digital PathologySystems by Country/Region - France, Germany, Italy, UK,Spain, and Rest of Europe Markets Independently Analyzedwith Annual Revenues in US$ Million for Years 2004 through2009 (includes corresponding Graph/Chart) III-42
Table 13: European 15-Year Perspective for Digital Pathology
Systems by Country/Region - Percentage Breakdown of Revenues
for France, Germany, Italy, UK, Spain and Rest of Europe
Markets for Years 2004, 2012, and 2018 (includes
corresponding Graph/Chart) III-43
5. ASIA-PACIFIC III-44A.Market Analysis III-44Current & Future Analysis III-44Product Launch III-44Strategic Corporate Development III-44B.Market Analytics III-45Table 14: Asia-Pacific Recent Past, Current and FutureAnalysis for Digital Pathology Systems with Annual Revenuesin US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-45
Table 15: Asia-Pacific Historic Review for Digital Pathology
Systems with Annual Revenues in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-46
6. REST OF WORLD III-47A.Market Analysis III-47Current & Future Analysis III-47Product Launch III-47B.Market Analytics III-48Table 16: Rest of World Recent Past, Current and FutureAnalysis for Digital Pathology Systems with Annual Revenuesin US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-48
Table 17: Rest of World Historic Review for Digital
Pathology Systems with Annual Revenues in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-49
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 46 (including Divisions/Subsidiaries - 51)
The United States (30)Canada (3)Japan (2)Europe (15)- Germany (6)- The United Kingdom (1)- Spain (1)- Rest of Europe (7)Asia-Pacific (Excluding Japan) (1)
To order this report:: Global Digital Pathology Systems Industry
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
Share this article